Alteration of urinary sorbitol excretion in WBN-kob diabetic rats - Treatment with an aldose reductase inhibitor

Journal of Endocrinology

Volumn 181, Issue 3, 2004, Pages 429-435

  Tsugawa, Toru ^a   Shinohara, Rikio ^a   Nagasaka, Akio ^a   Nakano, Itsuko ^a   Takeda, Fumiko ^a   Nagata, Minoru ^a   Oda, Naohisa ^a   Sawai, Yoshikuni ^a   Hayakawa, Nobuki ^a   Suzuki, Atsushi ^a   Itoh, Mitsuyasa ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; EPALRESTAT; POLYOL; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CELL FUNCTION; CONCENTRATION (PARAMETERS); DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME INHIBITION; KIDNEY TUBULE CELL; KIDNEY TUBULE DISORDER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; URINARY EXCRETION; URINE LEVEL;

ACETYLGLUCOSAMINIDASE; ALDEHYDE REDUCTASE; ANIMALS; DIABETIC NEPHROPATHIES; KIDNEY; MALE; MODELS, ANIMAL; RATS; RATS, WISTAR; RHODANINE; SORBITOL; THIAZOLIDINES;

EID: 3042725371     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1810429     Document Type: Article

References (33)

1. Clements RS Jr 1979 Diabetic neuropathy - new concepts of its etiology. Diabetes 28 604-611.
2. Gabbay KH 1973 The sorbitol pathway and the complications of diabetes. New England Journal of Medicine 288 831-836.
3. Gabbay KH 1975 Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annual Review of Medicine 26 521-536.
4. Giugliano D, Ceriello A & Paolisso G 1996 Oxidative stress and diabetic vascular complications. Diabetes Care 19 257-267.
5. Greene DA 1983 Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Metabolism 32 (Suppl 1) 118-123.
6. Greene DA & Lattimer SA 1983 Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. Journal of Clinical Investigation 72 1058-1063.
7. Greene DA, Lattimer S, Ulbrecht J & Carroll P 1985 Glucose-induced alterations in nerve metabolism - current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8 290-299.
8. Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S & Hotta N 1996 Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochemical and Biophysical Research Communications 228 539-543.
9. Hayashi R, Hayakawa N, Makino M, Nagata M, Kakizawa H, Uchimura K, Hamada M, Aono T, Fujita T, Shinohara R et al. 1998 Change in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor. Diabetes Care 21 672-673.
10. Hotta N 1995 New approaches for treatment in diabetes: aldose reductase inhibitors. Biochemical Pharmacology 5 232-243.
11. Hsiao PH, Tsai WS, Tsai WY, Lee JS, Tsau YK & Chen CH 1996 Urinary N-acetyl-beta-D-glucosaminidase activity in children with insulin-dependent diabetes mellitus. American Journal of Nephrology 16 300-303.
12. Ishii N, Ikenaga H, Ogawa Z, Aoki Y, Saruta T & Suga T 2001 Effects of renal sorbitol accumulation on urinary excretion of enzymes in hyperglycaemic rats. Annals of Clinical Biochemistry 38 391-398.
13. Itoh Y, Numata Y, Morita A, Asano Y & Kawai T 1994 Varied value of urinary N-acetyl-beta-D-glucosaminidase isoenzyme B in males of reproductive age. Kidney International - Supplement 47 S38-S42.
14. Kador PF, Robison WG Jr & Kinoshita JH 1985 The pharmacology of aldose reductase inhibitors. Annual Review of Pharmacology and Toxicology 25 691-714.
15. Kato H, Takashima T, Kishikawa H, Emura S & Ohmori K 1997 The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy. International Journal of Clinical Practice 51 489-490.
16. Kikkawa R, Umemura K, Haneda M, Arimura T, Ebata K & Shigeta Y 1987 Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 36 240-243.
17. + in normal, galactose-fed and diabetic rat lens. Biochimica et Biophysica Acta 841 247-253.
18. Malone JI, Knox G, Benford S & Tedesco TA 1980 Red cell sorbitol: an indicator of diabetic control. Diabetes 29 861-864.
19. Morita E, Kaizu K, Uriu K, Hashimoto O, Komine N & Eto S 1991 Clinical significance of urinary enzymes in diabetic nephropathy. Journal of Diabetes and its Complications 5 158-159.
20. Naeser P & Brolin SE 1991 Influence of glucose, fructose and aldose reductase inhibition on retinal sorbitol metabolism. Acta Opthalmologica 69 591-595.
21. Nakano I, Tsugawa T, Shinohara R, Watanabe F, Fujita T, Nagata M, Kato T, Himeno Y, Kobayashi T, Fujiwara K et al. 2003 Urinary sorbitol measurement and the effect of an aldose reductase inhibitor on its concentration in the diabetic state. Journal of Diabetes and its Complications 17 337-342.
22. Noco A, Ogawa Y, Mori S, Yoshioka M, Kitakaze T, Hori T, Nakamura M & Miyake T 1983 Simple, rapid spectrophotometry of urinary N-acetyl-beta-D-glucosaminidase, with use of a new chromogenic substrate. Clinical Chemistry 29 1713-1716.
23. Numata Y, Morita A, Kosugi Y, Shibata K, Takeuchi N & Uchida K 1997 New sandwich ELISA for human urinary N-acetyl-beta-D-glucosaminidase isoenzyme B as a useful clinical test. Clinical Chemistry 43 569-574.
24. Price RG 1992 Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine - methods and clinical applications. European Journal of Clinical Chemistry and Clinical Biochemistry 30 693-705.
25. Severini G, Aliberti LM & Di Girolamo M 1988 N-acetyl-beta-glucosaminidase isoenzymes in serum and urine of patients with diabetes mellitus. Clinical Chemistry 34 2430-2432.
26. Shinohara R, Mano T, Nagasaka A, Sawai Y, Uchimura K, Hayashi R, Hayakawa N, Nagata M, Makino M, Kakizawa H et al. 1998a Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats. Biochimica et Biophysica Acta 1425 577-586.
27. Shinohara R, Ohta Y, Yamauchi M & Ishiguro I 1998b Improved fluorometric enzymatic sorbitol assay in human blood. Clinica Chimica Acta 273 171-184.
28. Stevens MJ, Feldman EL & Greene DA 1995 The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diabetic Medicine 12 566-579.
29. UK Prospective Diabetes Study (UKPDS) 1993 IX: Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy. Diabetologia 36 835-842.
30. Wick AN & Drury DR 1951 Action of insulin on the permeability of cells to sorbitol. American Journal of Physiology 166 421-423.
31. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C & Tilton RG 1993 Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42 801-813.
32. Yamanouchi T, Kawasaki T, Yoshimura T, Inoue T, Koshibu E, Ogata N, Funato H, Akaoka I & Miyashita H 1998 Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up. Diabetes Care 21 619-624.
33. Yoshii H, Uchino H, Ohmura C, Watanabe K, Tanaka Y & Kawamori R 2001 Clinical usefulness of measuring urinary polyol excretion by gas-chromatography/mass-spectrometry in type 2 diabetes to assess polyol pathway activity. Diabetes Research and Clinical Practice 51 115-123.